1. Introduction {#sec1-life-10-00121}
===============

Selenium (Se) is an essential micronutrient in humans and animals, with selenoproteins exerting various metabolic functions \[[@B1-life-10-00121]\]. Among vertebrates, fishes have been described to have a well-developed selenoproteome \[[@B2-life-10-00121]\], but there is concern within the aquaculture sector with present feed formulations. The ongoing replacement of Se-rich fishmeal with plant protein sources \[[@B3-life-10-00121],[@B4-life-10-00121]\] is associated with a decrease in dietary Se level provided to farmed fish reared over a long period \[[@B5-life-10-00121],[@B6-life-10-00121]\]. Many of the characterized selenoproteins are known to influence antioxidant metabolism, but knowledge on the effects of dietary Se on other metabolic pathways is not well characterized \[[@B7-life-10-00121]\].

As shown *in vivo*, in the case of a Se deficiency, an increase in glutathione levels possibly relates to a feedback mechanism by changes in redox state \[[@B8-life-10-00121],[@B9-life-10-00121]\]. The major source for glutathione is cysteine, which is synthesized from homocysteine via the transsulfuration pathway \[[@B10-life-10-00121]\]. On the other hand, Se deficiency can impair the transsulfuration pathway with decreased levels of cysteine, cystathionine and homocysteine \[[@B11-life-10-00121],[@B12-life-10-00121]\]. Homocysteine is a key metabolite in the methionine cycle, which links the antioxidant system to one-carbon (1C) metabolism \[[@B13-life-10-00121]\]. Studies in mice have confirmed that Se affects methionine metabolism with decreased betaine homocysteine methyltransferase activity and S-adenosylhomocysteine (SAH) levels \[[@B14-life-10-00121],[@B15-life-10-00121],[@B16-life-10-00121]\]. Comparable studies in fish are lacking.

In the methionine cycle, methionine is activated by S-adenosylmethionine synthetase to form S-adenosylmethionine (SAM). In the cell, SAM is the universal donor for methylation reactions forming SAH. DNA methylation is a major regulatory mechanism for epigenetic modifications \[[@B17-life-10-00121]\]. DNA methylation at repeated cytosine phosphate guanine (CpG) residues, especially when localized at the promoter region, is considered to influence gene expression \[[@B18-life-10-00121]\]. Dietary supplementation of Se has been associated with both hyper- and hypomethylation in mice, but the relationship between Se and epigenetic mechanisms is still not fully understood \[[@B19-life-10-00121]\]. The present work therefore aims to study the effect of parental Se nutrition in rainbow trout (*Oncorhynchus mykiss*) on the 1C metabolism and the hepatic DNA methylation pattern of the progeny.

The period of embryonic development is extremely sensitive to environmental-induced epigenetic modifications. For example, the allocation of maternal gene products and nutrients to the yolk has been associated with regulation of key embryonic developmental processes and persisting changes in the phenotype of the progeny \[[@B20-life-10-00121],[@B21-life-10-00121]\]. In zebrafish (*Danio rerio*), dietary inclusion of methyl group donors did not lead to changes in hatching rate or survival, but mRNA sequencing of the embryos revealed "hidden" effects of parental nutrition \[[@B22-life-10-00121]\] which led to phenotypic changes at later life stages \[[@B23-life-10-00121]\]. In rainbow trout, the maternal Se nutrition during oogenesis increased not only the number of spawning females, but also the Se levels in the oocytes, especially when provided in the form of organic Se \[[@B6-life-10-00121]\]. Changing Se levels in the progeny during embryonic development were also associated with modifications in the oxidative status.

In fish diets, Se supplementation becomes increasingly important to make up for the low Se levels detected in diets based on plant protein sources \[[@B24-life-10-00121]\]. With regard to Se supplements, in addition to the widespread use of sodium selenite in terrestrial livestock nutrition, selenomethionine is the naturally dominant dietary seleno-compound, known to be a highly bioavailable form of Se also in mineral premixes \[[@B25-life-10-00121]\]. These seleno-compounds, however, might exert different impacts on the 1C metabolism as they are metabolized through different routes \[[@B26-life-10-00121]\]. Seleno amino acids are metabolized interchangeably with their sulfur analogues making selenomethionine to follow the methionine cycle, while inorganic Se compounds such as sodium selenite can be directly reduced to selenide to be incorporated into selenoproteins as selenocysteine \[[@B24-life-10-00121]\].

In this context, the present study aims to make a comparison between the use of sodium selenite and hydroxy-selenomethionine (OH-SeMet), a pure form of the hydroxy-analogue of selenomethionine, as dietary supplements in plant protein-rich feeds for rainbow trout broodstock on the 1C metabolism and the hepatic DNA methylation pattern of the progeny.

2. Results {#sec2-life-10-00121}
==========

2.1. Parental Selenium Affects Transsulfuration Metabolites in Swim-up Fry {#sec2dot1-life-10-00121}
--------------------------------------------------------------------------

A decrease in cysteine and cysteinyl-glycine was detected in liver of female broodstock only when fed sodium selenite (SS) compared to the non-supplemented control (NC). In addition, homocysteine levels were higher in fish fed OH-SeMet (SO) compared to the two other groups. No effect of the dietary Se on hepatic aminothiol concentrations was detected in males, which had generally lower hepatic aminothiol levels compared to females ([Table 1](#life-10-00121-t001){ref-type="table"}).

A parental effect of Se in swim-up fry could be detected for cysteine as well as cysteinyl-glycine, which were both significantly lower in fry originating from parents fed Se-supplemented diets compared to the NC group ([Table 2](#life-10-00121-t002){ref-type="table"}). This was accompanied by a decrease in pyridoxamine levels, but other B vitamins (folate and vitamin B12) including the pyridoxamine derivate pyridoxal were not significantly affected. Cystathionine, glutathione and γ-glutamyl-cysteine levels were not significantly different between the Se treatments. Similarly, parental Se treatment had no significant effect on the homocysteine level detected in swim-up fry.

2.2. Parental Selenium Nutrition Affects the Methionine Metabolism in Swim-up Fry {#sec2dot2-life-10-00121}
---------------------------------------------------------------------------------

In the whole body of swim-up fry, the methionine concentration was significantly decreased, when parents received Se-supplemented diets compared to fry from the NC group, with the lowest concentration observed in fries from SO treatment ([Table 1](#life-10-00121-t001){ref-type="table"}). The decreased methionine levels were accompanied by a general decrease in both essential and non-essential amino acids. PCA analysis of free amino acids and N-metabolites in fry revealed a strong clustering of the data according to the three parental groups dominated by essential amino acids, with the main contributing variables being lysine, isoleucine, valine, leucine, methionine, threonine and histidine besides glutamine, ammonium chloride and glycine ([Figure 1](#life-10-00121-f001){ref-type="fig"}). The only amino acid that was significantly higher in Se-supplemented treatments compared to the control was asparagine, with a 18 ± 4 µg/mg sample in NC vs. a 34 ± 3 µg/mg sample in SS and a 44 ± 5 µg/mg sample in SO.

In broodstock liver tissue, a reduction in the SAM/SAH ratio was detected for the Se-supplemented groups ([Figure 2](#life-10-00121-f002){ref-type="fig"}A). SAM levels in males and females were, however, strongly affected by inorganic Se, without a significant difference between NC and SO in males that showed higher SAM as well as SAH levels compared to females. In oocytes, no significant difference in SAM or SAH levels and the SAM/SAH ratio was detected between treatments.

In the whole body of swim-up fry, the SAM/SAH ratio was low in both Se-supplemented treatments compared to the control with the lowest SAM/SAH ratio detected in the SO group ([Figure 2](#life-10-00121-f002){ref-type="fig"}B). The decrease in the SAM/SAH ratio can be related to the comparatively lower SAM levels observed in this group.

2.3. Parental Selenium Affects mRNA Levels of Genes Related to the One-Carbon Metabolism in Swim-up Fry {#sec2dot3-life-10-00121}
-------------------------------------------------------------------------------------------------------

Gene expression levels in female liver tissue were not significantly different between groups. Methionine synthase (*mtr*) expression was higher in male liver tissue when the fish were fed Se-supplemented diets, with the highest expression in the SS treatment ([Figure 3](#life-10-00121-f003){ref-type="fig"}A). In addition, in male liver tissue, the expression of adenosylmethionine decarboxylase 1a (*amd1a*) was higher in SO compared to NC and that of glycine N-methyltransferase (*gnmt*) in SS compared to the other two dietary treatments. Except for adenosylmethionine decarboxylase 1b (*amd1b*) and *gnmt*, the expression of the 1C metabolism-related genes analyzed was higher in the females than in the males.

Parental feeding of both SS and SO increased *mtr* gene expression in the swim-up fry compared to NC feeding ([Figure 3](#life-10-00121-f003){ref-type="fig"}B). In addition, the expression of *amd1b* was higher in SS compared to NC and that of adenosylhomocysteinase (*sahh*) was higher in SO compared to the two other groups.

2.4. Parental Selenium Resulted in a Weak Group-Wise DNA Methylation Clustering {#sec2dot4-life-10-00121}
-------------------------------------------------------------------------------

Reduced representation bisulfite sequencing (RRBS) data were first processed and aligned to the rainbow trout genome ([Table A1](#life-10-00121-t0A1){ref-type="table"}). For downstream analysis, only uniquely mapped reads (47.6 ± 1.4%) were used. Of the 12 samples sequenced (4 per dietary group), none appeared as an outlier. In the search for the global methylation pattern with all the mapped CpG sites, t-SNE (t-distribution stochastic neighbor embedding) was used. The individual methylation pattern was stronger compared to group-wise global patterns, with only a weak group-wise clustering identified when using the 95th percentile of the CpC variance ([Figure 4](#life-10-00121-f004){ref-type="fig"}). The stronger individual variation compared to group-wise clustering was confirmed using other methods including PCA, hierarchical clustering and correlation analysis ([Figure A1](#life-10-00121-f0A1){ref-type="fig"}).

2.5. Data Alignment Gives a Balanced Hepatic Methylation Pattern between Groups {#sec2dot5-life-10-00121}
-------------------------------------------------------------------------------

The regional annotation showed that most of the mapped CpG originated with 51.8% from the gene bodies compared to the whole rainbow trout genome, where it accounts for 22.9% ([Figure 5](#life-10-00121-f005){ref-type="fig"}A). With 37.6%, most of the mapped CpG in the gene body were coming from the intron region. Further, promoters were more targeted by RRBS compared to the whole rainbow trout genome, with an increase from 4.7% to 7.2%.

The total number of differentially methylated cytosine (DMC) was comparable for the groups SS:NC (10904), SO:NC (11806) and SO:SS (13179) and, within each group, the number of hyper- and hypomethylated CpG sites was balanced even when divided into different sub-regions, exon and intron for the body and P250 for the proximal promoter, P1K for the promoter and P6K for the distal promoter region as well as flanks ([Figure 5](#life-10-00121-f005){ref-type="fig"}B).

2.6. Parental Selenium Affects the DNA Methylation Pattern in Several Metabolic Pathways {#sec2dot6-life-10-00121}
----------------------------------------------------------------------------------------

Comparing NC with the SS treatment showed a total of 6535 differentially methylated genes (DMGs) from which 1142 DMGs had DMCs located in the promoter region ([Figure 6](#life-10-00121-f006){ref-type="fig"}). Similarly, in total, 6890 DMGs were detected between NC and the treatment receiving SO with 1250 DMGs showing DMCs located in the promoter region. The highest number of DMGs was detected between the two different Se-supplemented treatments with a total of 7428 genes of which 1340 DMGs had DMCs located in the promoter region. A synergetic effect of Se in NC vs. SS and NC vs. SO was detected on 3663 genes, whereas SS vs. SO displays a specific effect of the Se source on 2387 genes.

In all datasets, multiple KEGG pathways were significantly enriched---22 in SS:NC, 18 in SO:NC and 20 in SO:SS ([Figure A2](#life-10-00121-f0A2){ref-type="fig"}). These KEGG pathways relate to diverse biological mechanisms, mainly cellular metabolism and environmental information processing, but also the organismal system and cellular processing.

Among the five genes with the highest number of DMCs listed for each of the sub-regions (exon, intron, proximal promoter, promoter and distal promoter) in [Table A2](#life-10-00121-t0A2){ref-type="table"}, [Table A3](#life-10-00121-t0A3){ref-type="table"} and [Table A4](#life-10-00121-t0A4){ref-type="table"}, three genes were common. The limbic system-associated membrane, transcript variant X5 protein (*Isamp*) belongs to the immunoglobulin super-family, known to be expressed and excreted in the developing forebrain showed 15 DMCs in SS:NC, 24 in SO:NC and 22 in SO:SS, all located in the intron region. The methylation pattern revealed both hyper- and hypomethylated CpG sites. The DMCs of the other two genes were located in the promoter region. The radical S-adenosyl methionine domain containing protein 2-like (*viperin*) is a cytoplasmic antiviral protein that is induced by interferons. *Viperin* had five DMCs in SS:NC and three DMCs in SO:NC and SO:SS, respectively. In the inorganic Se treatment, the CpG sites were hypomethylated, but they were hypermethylated in the organic Se treatment. The third gene was gamma-aminobutyric acid receptor subunit rho-2 (*gabrr2*), which is an inhibitory neurotransmitter in the vertebrate brain. The DMCs of *gabrr2* were located in the distal promoter region and similar to *viperin* the gene was hypomethylated in SS:NC and hypermethylated in SO:NC.

2.7. Parental Selenium also Affects Methylation in Genes Related to the 1C Metabolism {#sec2dot7-life-10-00121}
-------------------------------------------------------------------------------------

Several genes related to the methionine cycle and transsulfuration pathway were identified, but mostly they contained only single DMC sites ([Table 3](#life-10-00121-t003){ref-type="table"}). An effect on the genes that provide selenocysteine for the selenoprotein synthesis was only detected in the organic Se treatment. Nevertheless, selenoprotein I and selenoprotein U had DMCs in both Se-supplemented treatments.

3. Discussion {#sec3-life-10-00121}
=============

3.1. Parental Selenium Nutrition and the Transsulfuration Pathway in the Progeny {#sec3dot1-life-10-00121}
--------------------------------------------------------------------------------

Decreased levels of cysteine in rainbow trout fry originating from the parental group fed Se-supplemented diets are in contrast to reports in adult rats, mice and chicken, where rather an impaired transsulfuration with decreased cystathionine and cysteine levels has been described under dietary Se deficiency \[[@B12-life-10-00121],[@B14-life-10-00121],[@B15-life-10-00121]\]. Decreased levels of cysteine were also detected in liver tissue of female broodstock of the sodium selenite treatment, indicating an effect independent of life stage in rainbow trout ([Figure 7](#life-10-00121-f007){ref-type="fig"}). In the present study, swim-up fry of the Se-supplemented treatments had lower pyridoxamine levels compared to the control group, which indicates an increased demand for vitamin B6 by parental Se nutrition. The combined effect of maternal Se and pyridoxal nutrition has been studied in porcine embryos by Dalto et al. \[[@B27-life-10-00121],[@B28-life-10-00121]\], who described that the co-supplementation increased plasma seleno-dependent glutathione peroxidase levels in the progeny in the long term. In addition, the supply of organic Se and vitamin B6 stimulated the expression of elongation factors, biological processes related to translation and the mitotic cell cycle in five-day-old embryos \[[@B27-life-10-00121]\]. Although the sulfur and seleno amino acids follow a similar pathway, the most important reaction for selenocysteine is its reduction to selenide via selenocysteine lyase and further by selenophosphate synthetase that donates Se to the Sec-tRNA for the selenoprotein synthesis \[[@B26-life-10-00121]\]. Both these enzymes are vitamin B6 dependent, highlighting the importance of this vitamin in Se metabolism. This reaction is independent of dietary Se form as both inorganic and organic forms undergo the reduction to selenide \[[@B29-life-10-00121]\]. The impact of dietary Se form as observed in the present study could be questioned as in an earlier study it was shown that even in the parental sodium selenite treatment more than 94% of the Se in oocytes was either selenocysteine or selenomethionine \[[@B6-life-10-00121]\]. Nevertheless, the higher selenomethionine levels corresponding to the higher total Se levels in the organic Se treatment might contribute to changes in the methionine cycle, providing methyl groups and homocysteine/Se-homocysteine for the transsulfuration pathway. Thus, it can be inferred that the higher redox status of Se-homocysteine compared to homocysteine might favor transsulfuration, as its enzymes are readily regulated through the redox status \[[@B30-life-10-00121]\].

3.2. Parental Selenium Nutrition and the Methionine Cycle in the Progeny {#sec3dot2-life-10-00121}
------------------------------------------------------------------------

In the present study, parental Se had no effect on homocysteine levels in the swim-up fry, while studies in mice indicate an inverse correlation between liver Se and homocysteine levels \[[@B31-life-10-00121],[@B32-life-10-00121]\]. An increased mRNA level of *mtr* in both Se-supplemented treatments could indicate that in rainbow trout, parental Se favors the re-methylation of homocysteine to methionine in the offspring. An increase in homocysteine can result in the accumulation of SAH, which is a competitive inhibitor of methyl-transferases and therefore associated to global hypomethylation \[[@B19-life-10-00121]\]. In mammals, selenomethionine supplementation resulted in decreased hepatic SAH, but selenite on the contrary increased hepatic SAH \[[@B16-life-10-00121],[@B33-life-10-00121]\]. In the present study, the difference was not significant. Nevertheless, increased mRNA levels of *sahh* indicate that SAH might be increasingly metabolized to homocysteine in the organic Se treatment ([Figure 7](#life-10-00121-f007){ref-type="fig"}). The decrease in the SAM/SAH ratio in swim-up fry of Se-supplemented treatments due to a decrease in SAM levels is possibly due to the lower methionine levels. In the OH-SeMet treatment, it cannot be excluded that a competition of selenomethionine on active transporters reduced the methionine uptake in the gut \[[@B34-life-10-00121]\]. However, considering the small fraction that selenomethionine represents compared to dietary methionine levels in this study, it might be rather indicative of a higher methionine flux in the organic Se treatment. The sequence of Se-compounds in the metabolism creates an additional drain on methyl groups, as selenide and other highly reactive seleno-compounds can be spontaneously methylated \[[@B35-life-10-00121]\]. This process is of importance for inorganic Se sources which do not follow the methionine cycle and are directly reduced to selenide \[[@B36-life-10-00121]\]. This hypothesis is supported by our data on broodstock liver, where a significant decrease in SAM was only observed in the selenite treatment. This might be an explanation why Speckmann et al. \[[@B16-life-10-00121]\] reported a high SAM/SAH ratio in response to selenomethionine supplementation using Se-deficient conditions in mice where no methylation of seleno-compounds for removal could be expected. Several other studies in mice using higher Se levels detected no effect of Se on the SAM/SAH ratio \[[@B14-life-10-00121],[@B33-life-10-00121],[@B37-life-10-00121]\]. A depletion of the methyl donor SAM can result in decreased DNA methyltransferases (DNMT) activity \[[@B38-life-10-00121]\]. If in human colon carcinoma cells, administration of selenite inhibits DNMT activity \[[@B39-life-10-00121]\], *dnmt1* expression in the present study was not affected by Se, similar to what was reported on hepatic mRNA levels in mice \[[@B16-life-10-00121]\].

3.3. Parental Selenium Nutrition Affects the DNA Methylation Pattern of Genes Related to Several Metabolic Pathways {#sec3dot3-life-10-00121}
-------------------------------------------------------------------------------------------------------------------

Analyzed liver tissue of rainbow trout fry revealed that the DNA methylation patterns of several genes are sensitive to parental Se nutrition. Alterations in DNA methylation by Se have been reported in several murine studies, although with somewhat contradictory results, as Se could be associated with both hyper- and hypomethylation \[[@B16-life-10-00121],[@B33-life-10-00121],[@B37-life-10-00121],[@B40-life-10-00121]\]. The methylation of DNA can possibly regulate the spatial-temporal expression pattern of genes driving towards the development of a specific phenotype \[[@B18-life-10-00121]\]. Genes directly related to the sulfur and Se metabolism presented methylation differences according to parental Se nutrition. Therefore, epigenetic marks might relate to metabolic differences observed in the present as well as in an earlier study on the expression of genes involved in the glutathione and antioxidant metabolism in rainbow trout fry \[[@B6-life-10-00121]\]. Although an expected enrichment of the glutathione pathway could not be detected, genes of the glutathione metabolism including glutathione synthetase and glutathione-s-transferase kappa 1 were detected as DMGs. It has been reported that in cancer cells, selenite supplementation reactivates the transcription of glutathione-s-transferase π, another member of the glutathione-s-transferase family by a hypermethylation of the promoter region \[[@B41-life-10-00121]\]. Most studies with cancer cells generally report the methylation of selenoproteins like glutathione peroxidase 1 and 3, methionine sulfoxide reductase B1 and selenium binding protein 1 in the promoter region \[[@B42-life-10-00121]\]. In the present study with rainbow trout, parental Se nutrition did not result in changing methylation pattern for these genes, contrary to selenoprotein I, a potential target of parental Se nutrition on the progeny. Selenoprotein I is a protein involved in the formation of the glycerophospholipid phosphatidylethanolamine \[[@B43-life-10-00121]\], belonging to the glycophospholipid metabolism KEGG pathway that was enriched in the sodium selenite treatment. A silencing of the gene has been associated with impaired neural development as it is essential in the myelination process \[[@B44-life-10-00121]\]. In general, several genes with high changes in DNA methylation like *gabrr2* were related to brain signaling pathways and neurotransmission. Under physiologically relevant conditions, Se nutrition has been associated with a neuroprotective role on γ-aminobutyric acidergic neurons \[[@B45-life-10-00121]\]. It remains unclear whether the changes in DNA methylation of neuronal signaling genes as observed here in the hepatic tissue would be similarly detected in other organs such as the brain. DNA methylation works on a time and spatial dimension as genes gain tissue-dependent importance and are also activated and deactivated at different developmental stages \[[@B46-life-10-00121],[@B47-life-10-00121]\]. High methylation differences were also identified for genes with a role in immune protection, including the antiviral protein *viperin* that showed several DMC sites in the promoter region. *Viperin* was up-regulated by supra-nutritional Se feeding in rainbow trout as well as Atlantic salmon (*Salmo salar*) in earlier studies \[[@B48-life-10-00121],[@B49-life-10-00121]\]. This indicates that the impact of Se on the inflammatory response in fish might not be limited to direct feeding effects, but also be exerted through an epigenetic process. In this context, similar to other natural feed additives \[[@B50-life-10-00121]\], Se might act as an immunostimulant, improving fish immunity in the long term.

4. Materials and Methods {#sec4-life-10-00121}
========================

4.1. Experimental Set up {#sec4dot1-life-10-00121}
------------------------

The experiment was conducted at the INRAE experimental fish farm in Lées-Athas, France. Fish maintenance and experimental procedures were conducted by trained personnel in compliance with the European Directive 2010/63/EU for the protection of animals used for scientific purposes and the French Decree no. 2013--118 for animal experimentation.

Three-year-old rainbow trout (*Oncorhynchus mykiss*) broodstock (initial mean weight: 1.1 ± 0.2 kg in females and 0.9 ± 0.3 kg in males) from the same genetic group produced at the INRAE facilities of Lées-Athas (permit no. A64-104-1) were individually tagged and divided into three groups consisting of 25 females and 15 males. The fish were reared under natural photoperiod, as previously described \[[@B6-life-10-00121]\], over six months and fed the respective diets once daily to apparent satiation. At spawning, oocytes from eight females per group were fertilized with pooled sperm received from males of the same dietary treatment collected on the same day. Fertilized eggs from each female were reared separately in small trays until swim-up fry stage supplied with flow-through spring water at 8 ± 1 °C.

4.2. Experimental Diets {#sec4dot2-life-10-00121}
-----------------------

The diets were based on plant ingredients with an 8% fish oil inclusion and designed to differ only in their Se content ([Table 4](#life-10-00121-t004){ref-type="table"}), as previously described \[[@B6-life-10-00121]\]. The NC diet at a basal Se level of 0.3 mg/kg was not supplemented with Se. The SS diet was supplemented with sodium selenite to a target level of 0.6 mg/kg (analyzed concentration, 0.8 mg/kg) and the SO diet was supplemented to the same target level of 0.6 mg/kg with OH-SeMet (Selisseo®, Adisseo SAS, Antony, France), resulting in a final Se concentration of 0.7 mg/kg.

4.3. Sampling {#sec4dot3-life-10-00121}
-------------

The broodstock fish were anaesthetized with benzocaine for stripping and afterwards euthanized by a sharp blow to the head for liver dissection in both males and females. For each individual female, samples of pooled oocytes after stripping (1 g sized samples) and progeny at swim-up fry stage (whole-body fry) killed by an overdose of benzocaine were withdrawn. Moreover, a total of 36 individual swim-up fry livers were randomly dissected on the same day at the Ecology and Fish Population Biology facility in Saint-Pée-sur-Nivelle, France \[[@B52-life-10-00121]\], originating from 12 females (n = 4 females per dietary treatment). The three individual livers per female were pooled into a single sample tube for DNA extraction. All collected samples were immediately frozen in liquid nitrogen and stored at −80 °C until further analysis.

4.4. Metabolite Analysis {#sec4dot4-life-10-00121}
------------------------

In 0.1 g of pooled whole-body swim-up fry, free amino acids and other N-metabolites were analyzed using the Biochrome Analyzer and post column ninhydrin reaction following deproteinization, as previously described \[[@B53-life-10-00121]\]. The aminothiols of the transsulfuration and glutathione pathway including homocysteine, cysteine, γ-glutamyl-cysteine, reduced glutathione and cysteinyl-glycine as well as SAM and SAH were measured by HPLC using one sample extract. First, 0.3 g of broodstock liver tissue, 1 g of pooled oocytes or 1 g whole-body swim-up fry were homogenized with an ultra-turrax in a 20 mM phosphate, 1 mM EDTA (pH = 6.4) buffer. After centrifugation (10,000 g, 15 min, 4 °C), deproteinization of the supernatant was performed using a 10% metaphosphoric acid solution. The protocol for aminothiol analysis was adapted from Toyooka and Imai \[[@B54-life-10-00121]\]. Derivatization was performed by adding 62.5 µL AccQ·Fluor™ borate buffer (Waters, Guyancourt, France), 5 µL 1.55N NaOH and 4.5 mM ABD-F buffer to 25 µL sample aliquot for 20 min at 60 °C. After, the reaction was stopped by addition of 12.5 µL of 1N HCL and cooling at 4 °C for 15 min. Separation was performed using a AccQTaq^TM^ column at 40 °C using gradient elution: 0--2 min 97% A, 3% C; 20 min: 96% A, 4% C; 25 min: 20% B, 80% C; 30--35 min: 97% A, 3% C with (A) aqueous solution of AccQTag^TM^ Eluent A; (B) ultra-pure water and (C) methanol. Aminothiols were detected with fluorescence (excitation 385 nm, emission 515 nm). SAM/SAH measurement was adapted from She et al. \[[@B55-life-10-00121]\] with separation on a Revolve C18 at 40 °C with the following gradient: 0--10 min 95% A, 5% B; 20 min 30% A, 70% B; 35--45 min 95% A, 5% B with (A) 20mM phosphate buffer with 8mM OSA (pH 2.7, TFA adjusted) and (B) methanol. In 0.1 g of pooled whole-body swim-up fry, pyridoxine, pyridoxal and pyridoxamine were measured by ultra-performance liquid chromatography (UPLC) \[[@B56-life-10-00121]\] and vitamin B12 and total folate were analyzed microbiologically using *Lactobacillus delruceckii ssp. lactis* and *Lactobacillus rhamnosus*, respectively, as previously described \[[@B57-life-10-00121]\].

4.5. RNA Extraction and RT-qPCR {#sec4dot5-life-10-00121}
-------------------------------

The RNA was extracted and analyzed by quantitative RT-qPCR on 0.1 g samples of broodstock liver and a pool of three whole-body swim-up fry, as previously described \[[@B6-life-10-00121]\]. The primer sequences are given in [Table 5](#life-10-00121-t005){ref-type="table"}.

4.6. Statistical Analysis on Metabolic Analysis and Gene Expression Data {#sec4dot6-life-10-00121}
------------------------------------------------------------------------

Results are given as the mean ± SEM. Statistical analysis was performed using statistical software R (R Core Team). All data were tested for normality and homogeneity. Gene expression data were rank transformed before further analysis. Principle component analysis (PCA) was performed on the free amino acid dataset in search for biological clusters and outliers (R: factoextra \[[@B58-life-10-00121]\]). One-way ANOVA was used to identify differences between Se treatments or sex. Tukey's HSD was used as a post hoc test in case a significant difference (*p* \< 0.05) was detected.

4.7. DNA Extraction, RRBS Library Preparation and Sequencing {#sec4dot7-life-10-00121}
------------------------------------------------------------

DNA extraction on swim-up fry livers was performed using a QIAGEN DNeasy Blood and Tissue Kit (cat. no. 69504), following the manufacturer's instruction. DNA quantity was measured using Qubit fluorometric quantitation (Life Technologies, Carlsbad, California, USA), ensuring that the sample contained a minimum of 200 ng of DNA. The DNA extract was stored at −20 °C before DNA methylation was measured by reduced representation bisulfate sequencing (RRBS) performed at the Biomedical Sequencing Facility BSF in Vienna, Austria.

The RRBS library preparation was performed, as previously described \[[@B23-life-10-00121]\], on 100 mg genomic DNA including DNA digestion (Msp1 20 U, 16h at 37 °C), enzymatic adapter ligation (T4 DNA Ligase rapid), quantification and pooling. Bisulfite conversion was performed using EZ DNA Methylation-Direct Kit D5020, Zymo Research, but conversion reagent was used at 0.9× concentration with incubation for 20 cycles of 1 min at 95 °C, 10 min at 60 °C and a desulphonation time of 30 min to increase the number of CpG nucleotides covered. Enrichment PCR was performed after AMPure XP clean up and library concentrations were quantified with the Qubit Fluorometric Quantitation system (Life Technologies) and size distribution by a Bioanalyzer High Sensitive DNA Kit (Agilent). Sequencing was performed on Illumina HiSeq 3000/4000 instruments. The data have been stored in SRA \[[@B59-life-10-00121]\] under the accession number PRJNA629594.

4.8. Rainbow Trout Genome and Genomic Annotation {#sec4dot8-life-10-00121}
------------------------------------------------

The reference genome data of rainbow trout (Omyk_1.0) were downloaded from the NCBI assembly site (<https://www.ncbi.nlm.nih.gov/assembly/> GCF_002163495.1).

For genes with multiple RefSeq sequences, only the longest sequence was kept after eliminating overlapped isoforms. All the CpG sites in the genome were identified and split into four regions---gene body (GB), promoter (P), flanking regions around mRNA (flanks), and intergenic. Gene body was further divided into two sub-regions, intron and exon, whereas promoter was also divided based on the distance from the transcriptional start site (TSS) as P250 (1 bp--250 bp), P1K (251 bp--1000 bp) and P6K (1001 bp--6000 bp). Flanks were defined as a combination of 4K upstream from the 5′ end of P6Ks (equivalently 6001--10,000 bp from TSS) and 10K downstream of the 3′ end of mRNA. All the regions outside of gene bodies, promoters and flanks were annotated as intergenic. Each CpG site was defined as a unique and non-redundant region or sub-region according to the precedence of exon \> intron \> P250 \> P1K \> P6K \> flanks \> intergenic.

4.9. RRBS Data Processing {#sec4dot9-life-10-00121}
-------------------------

Illumina2bam tools (1.17.3; <https://github.com/wtsi-npg/illumina2bam>) were used to de-multiplex pooled samples. SAMtools \[[@B60-life-10-00121]\] was used to convert BAM files into FASTQ, before quality check by FastQC (Babraham Institute; <https://www.babraham.ac.uk>) and MultiQC \[[@B61-life-10-00121]\]. Adapters and low-quality reads in the RRBS mode based on Cutadapt \[[@B62-life-10-00121]\] were removed with Trim Galore! (Babraham Institute). Long reads were trimmed to 50 bp, and reads were selected by in-house python scripts to keep only those digested by MspI and TaqI.

Reads were aligned to the rainbow trout genome by Bismark \[[@B63-life-10-00121]\] with Bowtie 1 \[[@B64-life-10-00121]\]. Two Bismark tools, bismark_methylation_extractor and coverage2Cystosine, were used to retrieve methylation calls at CpG sites. Reads were filtered by methylKit tool \[[@B65-life-10-00121]\] when either the number of reads was above 99.9th percentile or less than or equal to 10.

Cluster analysis was performed by Rtsne \[[@B66-life-10-00121]\] for t-SNE \[[@B67-life-10-00121]\], with perplexity = 2 and factoextra \[[@B58-life-10-00121]\] for PCA, scree plot and hierarchical clustering with Ward's method.

Prior to differential methylation calculation, the unite function of methylKit was used to form SS:NC and SO:NC with NC as control and SO:SS with SS as control. Methylation differences were calculated by methylKit for all the CpG sites with methylation calls as a percentage and *p*-values by logistic regression. The SLIM method \[[@B68-life-10-00121]\] was used to calculate q-values. CpG sites with a q-value of \< 0.01 and ≥ 20% methylation difference were defined as differentially methylated cytosines (DMCs). Genes with at least one DMC in the gene body or promoter region are considered to be differentially methylated genes (DMGs).

In-house R and Python scripts were coordinated in a pipeline by using Snakemake \[[@B69-life-10-00121]\].

4.10. Functional Annotation and Statistical Analysis of DMGs {#sec4dot10-life-10-00121}
------------------------------------------------------------

To find Kyoto Encyclopedia of Genes and Genomes (KEGG) \[[@B70-life-10-00121]\] orthologues that correspond to rainbow trout genes, the results of BLASTKoala, GhostKoala \[[@B71-life-10-00121]\] and KEGG Automatic Annotation Server (KAAS) \[[@B72-life-10-00121]\] were merged. The precedence of BLASTKoala \> GhostKoala \> KASS was applied when conflicting annotation occurred. A total of 22501 orthologues along with 168 KEGG pathways were identified. Over representation analysis (ORA) on KEGG pathways and Gene Ontology (GO) terms \[[@B73-life-10-00121]\] was performed on DMGs by the R package clusterProfiler \[[@B74-life-10-00121],[@B75-life-10-00121]\].

The Wilcoxon signed-rank test (Wilcox) was used to test the differences of methylation rates between two groups in a pair-wise manner for KEGG pathways.

A bootstrap version of the Kolmogorov--Smirnov test (KS-boot; the number of iterations: 1000) was used to test the methylation differences that are associated with a KEGG pathway against the methylation differences of the whole CpG sites in a region. All three methods of enrichment analysis were performed for all the defined regions, and the *p*-values were adjusted by the Benjamini--Hochberg procedure.

5. Conclusions {#sec5-life-10-00121}
==============

Our results demonstrate that in rainbow trout, parental Se nutrition decreased transsulfuration and modified the methionine cycle, as summarized in [Figure 7](#life-10-00121-f007){ref-type="fig"}. A decrease in the methyl donor SAM was noticed in parental fish and their offspring by Se supplementation. In the offspring, significant changes in the DNA methylation pattern were identified, especially for genes related to signal transmission and immune function, by parental Se supplementation with organic and inorganic Se forms. It could be suspected that such epigenetic changes might persist during subsequent growth and development of the fish, leading to long-term molecular and metabolic alterations in the progeny, which deserves further investigation.
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Adenosylmethionine decarboxylase

bhmt

Betaine-homocysteine S-methyltransferase

cbs

Cystathionine beta-synthase

cgl

Cystathionine gamma-lyase

CpG

Cytosine phosphate guanine

DMCs

Differentially methylated cytosines

DMGs

Differentially methylated genes

DNMT

DNA methyltransferase

gnmt

Glycine N-methyltransferase

mtr

Methionine synthase

NC

Non-supplemented control treatment

OH-SeMet

Hydroxy-selenomethionine

RRBS

Representation bisulfite sequencing

SAH

S-adenosylhomocysteine

sahh

Adenosylhomocystenase

SAM

S-adenosylmethionine

SO

OH-SeMet treatment

SS

Sodium selenite treatment

life-10-00121-t0A1_Table A1

###### 

Alignment statistics of 12 RRBS samples.

  No       Name    Diet   Total Reads   Uniquely Mapped   (%)    Multi-Mapped   (%)    Non-Mapped   (%)
  -------- ------- ------ ------------- ----------------- ------ -------------- ------ ------------ ------
  **1**    PSL1    NC     53 987 762    26 310 305        48.7   19 820 505     36.7   7 856 952    14.6
  **2**    PSL2    NC     39 364 790    19 543 117        49.6   14 534 198     36.9   5 287 475    13.4
  **3**    PSL3    NC     54 833 812    27 173 708        49.6   20 233 149     36.9   7 426 955    13.5
  **4**    PSL4    NC     63 481 758    30 305 331        47.7   24 622 757     38.8   8 553 670    13.5
  **5**    PSL5    SS     59 570 698    27 527 855        46.2   23 489 555     39.4   8 553 288    14.4
  **6**    PSL6    SS     45 143 094    21 814 078        48.3   17 312 386     38.4   6 016 630    13.3
  **7**    PSL7    SS     67 495 806    31 151 354        46.2   27 389 024     40.6   8 955 428    13.3
  **8**    PSL8    SO     54 472 443    25 214 607        46.3   22 345 586     41.0   6 912 250    12.7
  **9**    PSL9    SO     69 558 057    33 562 782        48.3   26 840 717     38.6   9 154 558    13.2
  **10**   PSL10   SO     79 827 373    38 293 256        48.0   31 322 516     39.2   10 211 601   12.8
  **11**   PSL11   SO     55 391 941    25 516 081        46.1   21 796 848     39.4   8 079 012    14.6
  **12**   PSL12   SS     51 950 394    23 789 256        45.8   20 152 309     38.8   8 008 829    15.4

![Clustering of the 12 RRBS samples by different algorithms. (**A + B**) PCA biplot by dietary treatment. (**C + D**) Scree plot with percentage of explained variance within the top 10 dimensions of the PCA. (**E**) Heatmap with sample--sample distance calculated by normalized Pearson's correlation coefficient in a range between 0 and 1, with *d = 0* as *r = 1* and d=1 as *r = --1*. (**F**) Dendrogram with hierarchical clustering.](life-10-00121-g0A1){#life-10-00121-f0A1}

![Enriched KEGG pathways in SS:NC (**A**), SO:NC (**B**) and SO:SS (**C**), with the number of differentially methylated genes (DMGs).](life-10-00121-g0A2){#life-10-00121-f0A2}

life-10-00121-t0A2_Table A2

###### 

Top five DMGs in the dataset SS:NC, with the highest number of CpG in each sub-region.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                     Gene Symbol        Gene ID                                                                           Gene Name                                                            Total DMC   DMC in the Region   Hyper-/Hypomethylated CpG
  ------------------ ------------------ --------------------------------------------------------------------------------- -------------------------------------------------------------------- ----------- ------------------- ---------------------------
  Exon               LOC110496419       110496419                                                                         Glycoprotein endo-alpha-1,2-mannosidase-like protein                 10          10                  0/10

  LOC110503414       110503414          TCDD-inducible poly \[ADP-ribose\] polymerase-like                                10                                                                   8           8/0                 

  LOC110497587       110497587          SAM and SH3 domain-containing protein 1-like, transcript variant X2               10                                                                   7           0/7                 

  LOC110520294       110520294          Von Willebrand factor C domain-containing protein 2-like, transcript variant X1   7                                                                    7           5/2                 

  LOC110529233       110529233          MAM domain---containing glycosylphosphatidylinositol anchor protein 2-like        6                                                                    5           5/0                 

  Intron             CTNNA2             110534326                                                                         Catenin alpha-2                                                      18          18                  11/7

  alk                110506268          ALK receptor tyrosine kinase                                                      17                                                                   17          13/4                

  **lsamp**          **110507545**      **Limbic system-associated membrane protein, transcript variant X5**              **15**                                                               **15**      **9/6**             

  NRXN2-like         110531840          Neurexin-2-like                                                                   16                                                                   12          5/7                 

  CDH4-like          110532012          Cadherin-4-like                                                                   13                                                                   12          5/7                 

  P250               **LOC110498119**   **110498119**                                                                     **Radical S-adenosyl methionine domain-containing protein 2-like**   **5**       **5**               **0/5**

  LOC110493563       110493563          Septin-9-like                                                                     4                                                                    2           0/2                 

  COX6A2             100335037          Cytochrome c oxidase subunit VIa                                                  3                                                                    2           0/2                 

  TIMP2-like         110487076          Metalloproteinase inhibitor 2-like                                                2                                                                    2           0/2                 

  LOC110490026       110490026          Mitogen-activated protein kinase kinase kinase 8-like                             2                                                                    2           2/0                 

  P1K                LOC110534101       110534101                                                                         Matrin-3-like                                                        4           4                   4/0

  LOC110489756       110489756          Transmembrane protein 14C-like                                                    4                                                                    3           0/3                 

  LOC110486159       110486159          Proline-rich protein 15-like protein A                                            3                                                                    3           2/1                 

  TNFR11B-like       110506163          Tumor necrosis factor receptor superfamily member 11B-like                        3                                                                    3           0/3                 

  TPPP3X2-like       110518569          Tubulin polymerization-promoting protein family\                                  3                                                                    3           0/3                 
                                        Member 3-like, transcript variant X2                                                                                                                                                   

  P6K                COX4I2-like        110492636                                                                         Cytochrome c oxidase subunit 4 isoform 2, mitochondrial-like         8           8                   8/0

  LOC110523211       110523211          Oocyte zinc finger protein XlCOF6-like, transcript\                               8                                                                    8           0/8                 
                                        Variant X2                                                                                                                                                                             

  LOC110498688       110498688          Fatty acid-binding protein, liver-type-like                                       7                                                                    7           7/0                 

  **LOC110505815**   **110505815**      **Gamma-aminobutyric acid receptor subunit rho-2-**\                              **6**                                                                **5**       **0/5**             
                                        **like**                                                                                                                                                                               

  LOC110503024       110503024          Ras-related C3 botulinum toxin substrate 3-like                                   5                                                                    4           0/4                 
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Genes in bold are commonly highly affected also in SO:NC and SO:SS.

life-10-00121-t0A3_Table A3

###### 

Top five DMGs in the dataset SO:NC, with the highest number of CpG in each sub-region.

                     Gene Symbol        Gene ID                                                                           Gene Name                                                                        Total DMC   DMC in the Region   Hyper-/Hypomethylated CpG
  ------------------ ------------------ --------------------------------------------------------------------------------- -------------------------------------------------------------------------------- ----------- ------------------- ---------------------------
  Exon               LOC110490066       110490066                                                                         E3 ubiquitin-protein ligase rififylin-like, transcript variant X2                6           6                   5/1
  LOC110520294       110520294          von Willebrand factor C domain-containing protein 2-like, transcript variant X1   6                                                                                6           3/3                 
  LOC110531157       110531157          Serine/threonine-protein kinase WNK2-like                                         7                                                                                5           0/5                 
  LOC110497587       110497587          SAM and SH3 domain-containing protein 1-like, transcript variant X2               6                                                                                5           1/4                 
  LOC110506316       110506316          Muscarinic acetylcholine receptor M4-like, transcript variant X1                  6                                                                                5           0/5                 
  Intron             **lsamp**          **110507545**                                                                     **Limbic system-associated membrane protein, transcript variant X5**             **24**      **24**              **9/15**
  LOC110505581       110505581          Placenta growth factor-like                                                       15                                                                               15          9/6                 
  LOC110501635       110501635          Serine/threonine-protein kinase BRSK2-like                                        14                                                                               14          10/4                
  LOC110506270       110506270          Protein kinase C-binding protein NELL1-like, transcript variant X1                13                                                                               13          5/8                 
  Catenin alpha-2    110534326          Catenin alpha-2                                                                   13                                                                               13          6/7                 
  P250               LOC110501919       110501919                                                                         Alkyldihydroxyacetonephosphatesynthase,peroxisomal-like, transcript variant X2   5           3                   2/1
  LOC110494831       110494831          Complement C1q-like protein 2                                                     4                                                                                3           0/3                 
  LOC110508922       110508922          MARVEL domain-containing protein 2-like, transcript variant X2                    4                                                                                3           3/0                 
  CRIP2-like         110505831          Cysteine-rich protein 2-like                                                      3                                                                                3           3/0                 
  LOC110497531       110497531          Uncharacterized LOC110497531, transcript variant X2                               4                                                                                2           2/0                 
  P1K                LOC110493345       110493345                                                                         Gastrula zinc finger protein XlCGF17.1-like, transcript variant X1               4           4                   4/0
  LOC110521247       110521247          Lactadherin-like, transcript variant X1                                           4                                                                                4           4/0                 
  LOC110533598       110533598          Ras-related protein Rab-24-like, transcript variant X1                            4                                                                                4           0/4                 
  **LOC110498119**   **110498119**      **Radical S-adenosyl methionine domain-containing protein 2-like**                **3**                                                                            **3**       **3/0**             
  NFATC3-like        110506757          Nuclear factor of activated T-cells, cytoplasmic 3-like                           3                                                                                2           0/2                 
  P6K                **LOC110505815**   **110505815**                                                                     **Gamma-aminobutyric acid receptor subunit rho-2-like**                          **8**       **5**               **4/1**
  LOC110519930       110519930          Uncharacterized LOC110519930, transcript variant X2                               6                                                                                5           0/5                 
  LOC110520086       110520086          Collagen alpha-1(XXVIII) chain-like                                               5                                                                                5           3/2                 
  taf6l              110531860          TATA-box binding protein associated Factor 6 like, transcript variant X1          5                                                                                5           5/0                 
  LOC110537362       110537362          Glutamate receptor 3, transcript variant X3                                       5                                                                                5           5/0                 

Genes in bold commonly highly affected also in SS:NC and SO:SS.

life-10-00121-t0A4_Table A4

###### 

Top five DMGs in the dataset SO:SS, with the highest number of CpG in each sub-region.

                     Gene Symbol     Gene ID                                                              Gene Name                                                              Total DMC   DMC in the Region   Hyper-/Hypomethylated CpG
  ------------------ --------------- -------------------------------------------------------------------- ---------------------------------------------------------------------- ----------- ------------------- ---------------------------
  Exon               CDH2-like       110506386                                                            Neural-cadherin-like                                                   10          10                  7/3
  PLEKHG7-like       110497700       Pleckstrin homology domain-Containing family G member 7-like         9                                                                      9           0/9                 
  NRXN2-like         110531840       Neurexin-2-like                                                      21                                                                     8           2/6                 
  LOC110496419       110496419       Glycoprotein endo-alpha-1,2-mannosidase-like protein                 8                                                                      8           8/0                 
  LOC110496815       110496815       Glutamate receptor ionotropic, kainate5-like                         8                                                                      7           7/0                 
  Intron             **lsamp**       **110507545**                                                        **Limbic system-associated membrane protein, transcript variant X5**   **22**      **22**              **9/13**
  LOC110500600       110500600       Adhesion G protein-coupled receptor L3-like, transcript variant X5   23                                                                     20          17/3                
  FBXL17X1           110525966       F-box and leucine rich repeat protein 17, transcript variant X2      18                                                                     16          13/3                
  LOC110535694       110535694       Glutamate receptor ionotropic, delta-2, transcript variant X3        17                                                                     15          5/10                
  ZNF407-like        110501552       Zinc finger protein 407-like                                         16                                                                     15          3/12                
  P250               LOC110488021    110488021                                                            Calcitonin gene-related peptide type 1 receptor-like                   8           7                   7/5
  GATA 2-like        110494514       GATA-binding factor 2-like                                           7                                                                      6           6/0                 
  **LOC110498119**   **110498119**   **Radical S-adenosyl methionine domain-containing protein 2-like**   **4**                                                                  **3**       **3/0**             
  LOC110508922       110508922       MARVEL domain-containing protein 2-like, transcript variant X2       3                                                                      3           3/0                 
  CRIP2-like         110505831       Cysteine-rich protein 2-like                                         4                                                                      2           2/0                 
  P1K                LOC110527134    110527134                                                            Methyltransferase-like protein 7A                                      5           5                   0/5
  SEMA5A-like        110489566       Semaphorin-5A-like                                                   6                                                                      4           0/4                 
  LOC110493345       110493345       Gastrula zinc finger protein XlCGF17.1-like, transcript variant X1   4                                                                      4           4/0                 
  LOC100135939       100135939       Proteoglycan 4, transcript variant X2                                4                                                                      4           1/3                 
  GRTP1a-like        110527156       Growth hormone-regulated TBC Protein 1-A-like                        4                                                                      4           0/4                 
  P6K                LOC110523211    110523211                                                            Oocyte zinc finger protein XlCOF6-like,transcript variant X2           8           8                   8/0
  MARVELD2-like      110523471       MARVEL domain-containing protein 2-like                              8                                                                      8           8/0                 
  MED12-like         110488993       Mediator of RNA polymerase II transcription subunit 12-like          9                                                                      7           7/0                 
  LOC110522593       110522593       F-box only protein 31-like, transcript variant X1                    7                                                                      7           0/7                 
  **LOC110505815**   **110505815**   **Gamma-aminobutyric acid receptor subunit rho-2-like**              **6**                                                                  **6**       **6/0**             

Genes in bold are commonly highly affected also in SS:NC and SO:NC.

![PCA biplot of free amino acids and related compounds measured in whole-body swim-up fry. Arrows represent the 10 most contributing variables to the model. Ellipses represent the 95% confidence intervals around a center of eight pooled samples per dietary treatment.](life-10-00121-g001){#life-10-00121-f001}

![(**A**) SAM, SAH and the SAM/SAH ratio in whole-body swim-up fry; (**B**) SAM, SAH and the SAM/SAH ratio in broodstock tissue. Bars are the mean ± SEM (n = 8 in swim-up fry and female tissues and n = 5 in males). Means not sharing a common superscript letter are significantly different (*p* \< 0.05) according to one-way ANOVA followed by Tukey's HSD.](life-10-00121-g002){#life-10-00121-f002}

###### 

(**A**) Relative mRNA levels in whole-body swim-up fry from rainbow trout subjected to different Se treatments; (**B**) relative mRNA levels in parental liver tissue from rainbow trout subjected to different Se treatments. Data are normalized to β-actin and expressed as fold changes compared with the control group NC. In A, values are expressed relative to NC males. Bars are the mean ± SEM (A: n = 8; B n = 8 in female liver and n = 5 in male liver). Means not sharing a common superscript letter are significantly different (*p* \< 0.05) according to one-way ANOVA followed by Tukey's HSD.

![](life-10-00121-g003a)

![](life-10-00121-g003b)

![t-SNE analysis with the CpG sites using either the \> 50% or \> 95% quantile.](life-10-00121-g004){#life-10-00121-f004}

![(**A**) Regional distributions of mapped/original CpG. (**B**) Regional distributions of methylation differences of the differentially methylated cytosines (DMC) with a 20% threshold. Three violin plots show the density of overall methylation differences for SS:NC, SO:NC, and SO:SS, with scattered dots indicating DMC.](life-10-00121-g005){#life-10-00121-f005}

![Venn diagrams summarizing the analysis of genes with different methylation patterns in NC vs. SS, NC vs. SO and SS vs. SO. (**A**) Genes are included with at least one DMC in gene body or promoter region; (**B**) Genes are included with at least one DMC in the promoter region.](life-10-00121-g006){#life-10-00121-f006}

![Effect of parental Se nutrition on the methionine cycle and transsulfuration pathway in the progeny of rainbow trout. Superscript indicates that the effect was only detected in the respective treatment.](life-10-00121-g007){#life-10-00121-f007}
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###### 

Aminothiol concentrations (µg/g sample) measured in liver and oocytes of rainbow trout (*Oncorhynchus mykiss*) broodstock fed diets containing different levels and source of Se.

                                 Homocysteine    Cysteine       Cysteinyl-Glycine   Glutathione    γ-Glutamyl-Cysteine
  -------------- --------------- --------------- -------------- ------------------- -------------- ---------------------
  Oocyte         NC              0.3 ± 0.0       6.7 ± 1.0      3.7 ± 0.4           16 ± 1         1.0 ± 0.1
  SS             0.3 ± 0.0       6.7 ± 0.6       4.1 ± 0.5      17 ± 1              1.0 ± 0.1      
  SO             0.2 ± 0.0       8.1 ± 1.1       3.1 ± 0.3      13 ± 1              1.0 ± 0.1      
  *p-value*      *0.21*          *0.48*          *0.35*         *0.07*              *0.48*         
  Female liver   NC              1.4 ± 0.1 ^b^   33 ± 4 ^a^     53 ± 4 ^a^          551 ± 32       30 ± 4
  SS             1.1 ± 0.1 ^b^   17 ± 2 ^b^      37 ± 3 ^b^     530 ± 32            23 ± 2         
  SO             3.2 ± 0.3 ^a^   38 ± 3 ^a^      48 ± 3 ^ab^    526 ± 47            28 ± 3         
  *p-value*      ***\<0.01***    ***\<0.01***    ***0.01***     *0.88*              *0.29*         
  Male liver     NC              0.7 ± 0.1       21 ± 3         26 ± 3              511 ± 64       21 ± 2
  SS             1.0 ± 0.2       24 ± 5          23 ± 3         300 ± 66            10 ± 2         
  SO             1.1 ± 0.3       33 ± 8          27 ± 4         465 ± 30            16 ± 5         
  *p-value*      *0.49*          *0.33*          *0.80*         *0.06*              *0.48*         
  Average        Female          1.9 ± 0.2 ^a^   29 ± 2         46 ± 2 ^a^          536 ± 22 ^a^   27 ± 2 ^a^
  Male           0.9 ± 0.1 ^b^   26 ± 3          25 ± 2 ^b^     434 ± 39 ^b^        13 ± 2 ^b^     
  *p-value*      ***\<0.01***    *0.43*          ***\<0.01***   ***0.02***          ***\<0.01***   

Values are the mean ± SEM (n = 8 in female tissue and n = 5 in males). ^a,b^ Within-rows values not sharing a common superscript letter are significantly different (*p* \< 0.05) according to one-way ANOVA followed by Tukey's HSD.

life-10-00121-t002_Table 2

###### 

Free amino acid, aminothiol, and B vitamin composition of swim-up fry from broodstock fed the different diets.

  Dietary Group                   NC                SS                SO                *p*-Value
  ------------------------------- ----------------- ----------------- ----------------- ------------
  Essential amino acids ^1^       1972 ± 79 ^a^     1737 ± 54 ^b^     1400 ± 65 ^c^     **\<0.01**
  Non-essential amino acids ^1^   2415 ± 50 ^a^     2351 ± 41 ^a^     2109 ± 60 ^b^     **\<0.01**
  Methionine ^1^                  99 ± 5 ^a^        83 ± 3 ^b^        56 ± 4 ^c^        **\<0.01**
  Homocysteine ^1^                1.2 ± 0.1         1.1 ± 0.1         1.2 ± 0.1         0.86
  Cystathionine ^1^               9 ± 1             6 ± 1             7 ± 1             0.21
  Cysteine ^1^                    21 ± 1 ^a^        17 ± 1 ^b^        17 ± 0 ^b^        **0.01**
  Cysteinyl-glycine ^1^           28 ± 1 ^a^        24 ± 1 ^b^        24 ± 1 ^b^        **0.02**
  Glutathione ^1^                 179 ± 7           159 ± 7           169 ± 13          0.35
  γ-Glutamyl-cysteine ^1^         18 ± 1            17 ± 1            16 ± 1            0.25
  Taurine ^1^                     688 ± 17          751 ± 18          724 ± 16          0.05
  Pyridoxamine ^2^                0.24 ± 0.01 ^a^   0.21 ± 0.02 ^b^   0.18 ± 0.01 ^b^   **0.01**
  Pyridoxal ^2^                   1.82 ± 0.08       1.65 ± 0.06       1.85 ± 0.10       0.17
  Folate ^2^                      0.36 ± 0.03       0.37 ± 0.02       0.28 ± 0.02       0.05
  Cobalamine ^2^                  0.04 ± 0.00       0.04 ± 0.00       0.03 ± 0.00       0.51

^1^ (µg/g sample); ^2^ (µg/mg sample). Values are the mean ± SEM (n = 8). ^a,b,c^ Within-rows values not sharing a common superscript letter are significantly different (*p* \< 0.05) according to one-way ANOVA followed by Tukey's HSD.
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###### 

Differentially methylated genes (DMGs) related to sulfur and selenium metabolism.

  DMGs                                             Hyper-/Hypomethylated DMC                                                                       
  ------------------------------------------------ --------------------------------------------------------------------------- --------- --------- ---------
  Gene ID                                          Gene name                                                                   SS:NC     SO:NC     SO:SS
  **Methionine Cycle**                                                                                                                             
  110530927                                        S-adenosylmethionine synthase                                               0/1                 
  110537066                                        S-adenosylmethionine synthase-like                                                    0/1       0/2
  110502651                                        S-adenosylmethionine synthase-like                                          1/0 ^P^   0/2       1/0
  110529528                                        S-adenosylmethionine decarboxylase proenzyme-like                                     0/1       0/1
  110538418                                        DNA (cytosine-5)-methyltransferase 1-like, transcript variant X1                      0/1       
  110505844                                        DNA (cytosine-5)-methyltransferase 3A-like                                            1/0       
  110532515                                        DNA (cytosine-5)-methyltransferase 3A-like, transcript variant X2                               1/0
  110497603                                        DNA (cytosine-5)-methyltransferase 3A-like, transcript variant X6           1/0                 
  110492301                                        DNA (cytosine-5)-methyltransferase 3B-like, transcript variant X1                               1/0
  110500231                                        Putative adenosylhomocysteinase 3                                                     0/1 ^P^   
  110494352                                        S-adenosylhomocysteine hydrolase-like protein 1 transcript variant X1                 1/0       
  110490243                                        Adenosylhomocysteinase 3-like                                               2/1       4/2       0/1
  110522167                                        Putative adenosylhomocysteinase 3, transcript variant X2                                        0/1
  **Glutathione Metabolism**                                                                                                                       
  110521555                                        Glutamate---cysteine ligase regulatory subunit-like                         0/1                 
  110502703                                        Glutamate---cysteine ligase catalytic subunit-like, transcript variant X2   0/1                 
  110532297                                        Glutathione synthetase                                                                0/1 ^P^   
  110522620                                        Glutathione-specific gamma-glutamylcyclotransferase 1-like                            2/0       
  110537206                                        Gamma-glutamyltransferase 5-like,transcript variant X1                      0/1 ^P^   1/0 ^P^   2/0 ^P^
  100305229                                        Glutathione S-transferase kappa 1, transcript variant X1                                        1/0 ^P^
  110492369                                        Glucose-6-phosphate 1-dehydrogenase-like, transcript variant X2                       2/0       0/1
  100305228                                        Peroxiredoxin 6, transcript variant X2                                                1/0       
  110532317                                        Spermidine synthase                                                                   0/1 ^P^   
  110535309                                        5-oxoprolinase (ATP-hydrolyzing)                                                      0/1       1/2
  110501851                                        Isocitrate dehydrogenase \[NADP\] cytoplasmic-like                          1/0 ^P^             0/1 ^P^
  110520228                                        Isocitrate dehydrogenase \[NADP\] cytoplasmic-like                                    1/1       
  **Selenoprotein Synthesis and Selenoproteins**                                                                                                   
  110494778                                        Methionyl-tRna synthetase 1                                                           0/1       0/1
  110488988                                        Methionyl-tRNA synthetase 2, mitochondrial                                  1/0                 
  110500323                                        Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase                                   1/0 ^P^
  110512109                                        tRNA selenocysteine 1-associated protein 1-like                                       0/1       
  110528137                                        Eukaryotic elongation factor, selenocysteine-tRNA specific                            1/0       
  110529243                                        Selenoprotein I                                                             0/3       5/0       7/0
  100499413                                        Selenoprotein U                                                             0/1 ^P^   1/0 ^P^   1/0 ^P^
  110532070                                        Selenoprotein K, transcript variant X1                                                0/1       
  110497881                                        Selenoprotein O-like                                                                            1/0
  110525853                                        Thioredoxin reductase 2                                                                         0/1

^P^ located at the promoter region.
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###### 

Dietary composition.

  Diet                                                 NC        SS         SO
  ---------------------------------------------------- --------- ---------- ----------
  *Ingredients*                                                             
  Plant meals ^1^                                      74        74         74
  Crystalline amino acids and attractant mixture ^2^   3.14      3.14       3.14
  Soybean lecithin^3^                                  2         2          2
  Fish oil ^3^                                         8         8          8
  Vegetable oils ^4^                                   8         8          8
  Astaxanthin (µg/g diet) ^5^                          40        40         40
  Vitamin and mineral mixture without Se ^6^           4.82      4.82       4.82
  Sodium selenite (µg/g diet) ^7^                      --        **0.71**   --
  Hydroxy-selenomethione (µg/g diet) ^7^               --        --         **0.75**
  *Analytical composition*                                                  
  Dry matter (DM, %)                                   96        98         97
  Crude protein (% DM)                                 49        50         50
  Total lipid (% DM)                                   23        22         23
  Gross energy (kJ/g DM)                               25        25         25
  Ash (% DM)                                           6         6          6
  Phosphorus (% DM)                                    1.2       1.1        1.2
  Selenium (mg/kg dry feed) ^8^                        **0.3**   **0.8**    **0.7**

^1^ Plant meals (% diet): 20% wheat gluten (Roquette), 18% corn gluten meal (Inzo), 15% soybean protein concentrate Estril®75 (Sopropêche), 6% soybean meal (Sud-Ouest Aliment), 5% rapeseed meal 00 (Sud-Ouest Aliment), 5% white lupin meal Farilup 500 (Terrena), 3% dehulled pea meal Primatex (Sotexpro), 2% whole wheat (Sud-Ouest Aliment). ^2^ Crystalline amino acids and attractant mixture (% diet): 1.34% L-lysine, 0.3% DL-methionine, 0.5% glucosamine, 0.3% taurine, 0.3% betaine, 0.2% glycine, 0.2% alanine. ^3^ Soybean lecithin from Louis François and fish oil from Sopropêche. ^4^ Vegetable oils (% diet): 4% rapeseed oil, 2.4% linseed oil, 1.6% palm oil (Daudry). ^5^ Provided as Carophyll® pink (DSM). ^6^ Vitamin and mineral mixture without Se (per kg diet): retinol acetate, 55,000 IU; cholecalciferol, 2,500 IU; DL-α-tocopherol acetate, 50 IU; sodium menadione bisulfate, 10 mg; thiamin-HCl, 1 mg; riboflavin, 4 mg; niacin, 10 mg; D-calcium pantothenate, 20 mg; pyridoxine-HCl, 3 mg; D-biotin, 0.2 mg; folic acid, 1 mg; cyanocobalamin, 10 µg; L-ascorbyl-2-polyphosphate, 50 mg; myo-inositol, 0.3 g; choline, 1 g; CaHPO~4~·2H~2~O, 33 g; CaCo~3~, 2.15 g; Mg(OH)~2~, 1.24 g; KCl, 0.9 g; NaCl, 0.4 g; FeSO~4~·7H~2~O, 0.2 g; ZnSO~4~·7H~2~O, 40 mg; MnSO~4~·H~2~O, 30 mg; CuSO~4~·5H~2~O, 30 mg; NaF, 10 mg; KI, 0.4 mg; CoCl~2~·6H~2~O, 0.2 mg. All ingredients were diluted with α-cellulose. ^7^ Sodium selenite contained 42% Se (Sigma-Aldrich) and hydroxy-selenomethionine contained 40% Se provided as Selisseo® (Adisseo). ^8^ Total Se was determined using inductively coupled plasma mass spectrometry (ICP MS, Agilent series 7500cx) by Ultra-Trace Analysis Aquitaine (UT2A, Pau, France) according to Vacchina and Dumont \[[@B51-life-10-00121]\], with a calculated uncertainty of 15 µg/kg and a limit of quantification of 3 µg/kg.
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###### 

Oligonucleotide primers used to assay mRNA levels by Fluidigm PCR.

  Gene        Accession No.    Forward Primer          Reverse Primer          Amplification Size
  ----------- ---------------- ----------------------- ----------------------- --------------------
  *amd1a*     XM_021611778.1   ccgtaccatcccaaggtttga   tcctgcttgtcggtctttgt    87
  *amd1b*     XM_021600287.1   cagccagattttcccaaacgg   gcatgctcgttctcccagaa    108
  *bhmt*      FR908041.1       cagagaagcacggtaactgg    ttctttgtgctgcatcaggt    188
  *cbs*       NM_001124686.1   ccacctcaggcaatacaggt    aacatccaccttctccatgc    107
  *cgl*       EU315111.1       caccaaccccaccatgaaag    gcgctggaagtaggctgaca    118
  *dnmt1*     XM_021557911.1   ttgccagaagaggagatgcc    cccaggtcagcttgccatta    152
  *gnmt*      XM_021585680.1   ctcaagtacgcgctgaagga    cactctggtcccctttgaagt   187
  *mtr*       XM_021576690.1   aatgcaggtctgcccaatac    ctgatgtgtgcaggagtcgt    137
  *sahh*      XM_021609053.1   atcaaacgggccacagatgt    tcgtaccttccatggcagc     167
  *β-actin*   AJ438158.1       gatgggccgaaagacagcta    tcgtcccgtggtgacgat      105

*amd1*, adenosylmethionine decarboxylase 1; *bhmt*, betaine-homocysteine S-methyltransferase 1; *cbs*, cystathionine beta-synthase; *cgl*, cystathionine gamma-lyase; *dnmt1*, DNA methyltransferase 1; *gnmt*, glycine N-methyltransferase; *mtr*, methionine synthase; *sahh*, adenosylhomocysteinase.

[^1]: These authors contributed equally to this work.
